progression-free survival
Ibrutinib Bests Drug Combo in Older CLL Pts
In older patients with newly diagnosed chronic lymphocytic leukemia (CLL), ibrutinib provided a significant ...
MARCH 11, 2019
FDA Approves New Indication for Lenvima for HCC
The FDA approved a new indication for Lenvima for first-line treatment of patients with unresectable hepatocellular ...
AUGUST 17, 2018
Load more